A phase 2 study of the combination of decitabine (DAC), venetoclax (VEN), and ponatinib in patients (Pts) with chronic myeloid leukemia (CML) in accelerated phase (AP)/myeloid blast phase (MBP) or ...

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC ...

TAQXpedite Was Designed to Reduce PCR Cycling Times in a Variety of Applications Fast PCR can be achieved with fast PCR instrumentation or by using enzyme/reagent combinations that improve speed and ...

Eppendorf Biochip Systems is developing a technology called RAP™ (Real-time Array PCR) or RAP-ID™ that combines the advantages of qPCR and microarrays, i.e., the multiplexing capabilities of ...